These results indicated that HOXC6 mRNA expression might be linked with poor clinical prognosis and are consistent with previous studies, which were conducted in GC and other malignant tumors such as prostate cancer, esophageal cancer and hepatocellular carcinoma [20, 22, 25, 26]. Here, HOXC6 is linked to prostate carcinoma.